58 Days
Source:
الوقائع الإخبارية
Jordan registers first locally produced pneumococcal vaccine, marking a significant leap in pharmaceutical manufacturing
The Jordan Food and Drug Administration announced the registration of the first locally manufactured vaccine for pneumococcal prevention, called TQ-PCV. This achievement is the result of a technical and manufacturing partnership with China. The new vaccine, aimed at children from three months to five years old, seeks to provide broad protection against thirteen serotypes of the bacteria responsible for respiratory diseases. It is based on rigorous studies and examinations to ensure safety and efficacy standards. This milestone represents an important step towards strengthening pharmaceutical security in the country, reducing dependency on imports, and localizing the biopharmaceutical industry in line with the national vision to transform Jordan into a regional hub for producing innovative medicines and vaccines.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)